| 000 | 01126 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515033517.0 | ||
| 264 | 0 | _c20060822 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a1381-6128 | ||
| 024 | 7 |
_a10.2174/138161206777698747 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBainbridge, John | |
| 245 | 0 | 0 |
_aAngiogenesis as a therapeutic target in arthritis: lessons from oncology. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2006 |
||
| 300 |
_a2631-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aNeoplasms _xblood supply |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
| 700 | 1 | _aSivakumar, Branavan | |
| 700 | 1 | _aPaleolog, Ewa | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 12 _gno. 21 _gp. 2631-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/138161206777698747 _zAvailable from publisher's website |
| 999 |
_c16432961 _d16432961 |
||